Plus Therapeutics Files 2024 Annual Report Amendment
Ticker: PSTV · Form: 10-K/A · Filed: Apr 30, 2025 · CIK: 1095981
| Field | Detail |
|---|---|
| Company | Plus Therapeutics, Inc. (PSTV) |
| Form Type | 10-K/A |
| Filed Date | Apr 30, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: amendment, annual-report, company-update
TL;DR
Plus Therapeutics filed its 2024 10-K amendment, updating investors on company status.
AI Summary
Plus Therapeutics, Inc. filed an amendment (10-K/A) to its annual report for the fiscal year ended December 31, 2024. The filing, submitted on April 30, 2025, provides updated information for the company, previously known as Cytori Therapeutics, Inc. and Macropore Inc. The company is headquartered in Austin, Texas.
Why It Matters
This amendment provides updated financial and operational information for Plus Therapeutics, Inc., crucial for investors to assess the company's performance and outlook.
Risk Assessment
Risk Level: medium — As a publicly traded company filing an annual report amendment, there's inherent risk associated with financial reporting and potential changes in disclosed information.
Key Players & Entities
- PLUS THERAPEUTICS, INC. (company) — Registrant
- December 31, 2024 (date) — Fiscal year end
- April 30, 2025 (date) — Filing date
- CYTORI THERAPEUTICS, INC. (company) — Former company name
- MACROPORE INC (company) — Former company name
- Austin, Texas (location) — Company headquarters
FAQ
What is the purpose of this 10-K/A filing?
This 10-K/A filing is an amendment to the annual report for the fiscal year ended December 31, 2024, providing updated information for Plus Therapeutics, Inc.
When was this amendment filed with the SEC?
The amendment was filed on April 30, 2025.
What was Plus Therapeutics, Inc. previously known as?
Plus Therapeutics, Inc. was formerly known as Cytori Therapeutics, Inc. and Macropore Inc.
Where is Plus Therapeutics, Inc. headquartered?
The company's business address is listed as 4200 Marathon Blvd., Suite 200, Austin, TX 78756.
What is the SEC file number for Plus Therapeutics, Inc.?
The SEC file number for Plus Therapeutics, Inc. is 001-34375.
Filing Details
This Form 10-K/A (Form 10-K/A) was filed with the SEC on April 30, 2025 regarding PLUS THERAPEUTICS, INC. (PSTV).